|
January 20, 2010 Early Stage Company Advisors, Advisory Board Members
Mark Soane (Moderator) is a Managing Director of Appian Venture Partners, an early-stage technology fund based in Denver. Mr. Soane serves on or has served on over a dozen corporate boards, including Voyant Technologies (sold to Polycom), Carefx, OneRiot, OpenLogic and Ischemia Technologies (sold to Inverness Medical) and was a board observer at Veritas Software (acquired by Symantec). He served as Executive Chairman of Controlled Products Group and led its turnaround and sale to Pilgrim Capital. He has also held executive level marketing and operations positions at several venture-backed companies, including Personics Corporation, TRADE Inc. and Multum Information Services. Mr. Soane is a former Chairman of the Colorado Venture Capital Association and Chairman of the Colorado Fourteeners Initiative. He was recently reappointed by Colorado Senate President to the Colorado Venture Capital Authority. He holds a bachelor's degree in History from Dartmouth College and an MBA from Stanford Business School. Dr. Richard Duke is a biotechnology executive, inventor, biomedical researcher and serial entrepreneur with over fourteen years of experience in building, financing and managing start-up biotechnology companies based on inventions made in Colorado's non-profit research institutions. He is currently Co-scientific Founder, President and CEO of ApopLogic Pharmaceuticals. He is a Co-scientific Founder and former CEO, President and Director of GlobeImmune, Inc. and its predecessor Ceres Pharmaceuticals. These Colorado-based companies have raised in excess of $100 million in private financing and have multiple products in preclinical, phase 1 and 2 human clinical trials in cancer and infectious diseases. In addition to his entrepreneurial activities, Dr. Duke has over twenty-five years of experience in biomedical research and is a tenured faculty member in the Departments of Medicine (Medical Oncology) and Immunology at the University of Colorado Denver. He also serves as a Director of the newly formed Colorado Institute for Drug, Device and Diagnostic Development whose mission is to accelerate the process of transforming research discoveries into commercial products to cure and treat human disease while creating new jobs and life science companies in Colorado. Bill Perry co-founded SoftBridge Advisors twenty years ago. Under his leadership, SoftBridge has logged three IPOs, seventeen successful mergers and raised or assisted in over forty financings totaling $350 million. Mr. Perry came to Colorado in 1982 as President of Precision Visuals, Inc. (a graphics software company). He built the venture from a ten person garage shop into number 49 on the Top 100 Software Company list. More recently, he developed Webroot Software, Inc. into his second Top 100 company and has added clean technology ventures to SoftBridge’s activities. Mr. Perry spent the early years of his career in large corporations, with key assignments as marketing manager for a $1billion line of industrial products, and as chief financial officer of a rapidly growing, Latin American telecom group. He holds an engineering degree from MIT, an MBA from Harvard, and is a recipient of Esprit’s Lifetime Achievement Award for Entrepreneurship. Time: 7:00 AM Location: Denver Country Club Agenda: ******
|
